Skip to main content
OpenTrials

Clinical trial condition

Gram-Negative Bacterial Infections

Explore clinical trials studying Gram-Negative Bacterial Infections. Study availability and eligibility vary by location and protocol.

1,462 public trials 132 recruiting studies
Refine in advanced search Browse all conditions

Gram-Negative Bacterial Infections trial results

Completed

Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin

NCT00634192

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +2 more
Locations
  • Novartis Investigator Site Berlin, Germany
  • Novartis Investigator Site Cologne, Germany
  • Novartis Investigator Site Frankfurt, Germany
  • Novartis Investigator site Halle, Germany
View Trial Details
Completed

Prevention of Urinary Tract Infection (UTI) in Persons With Spinal Cord Injury (SCI)

NCT00309114

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Enterobacteriaceae Infections, +9 more
Locations
  • Shepherd Center Atlanta, Georgia, United States
  • Rehab Institute Chicago Chicago, Illinois, United States
  • UT Southwestern Dallas, Texas, United States
  • Michael E Debakey VA Medical Center Houston, Texas, United States
View Trial Details
Completed

Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients

NCT01320358

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Behavior, +9 more
Locations
  • Kantonspital Aarau AG / Nephrologie Aarau, Switzerland
  • University Hospital Basel Basel, Switzerland
  • Inselspital Bern / Nephrology Bern, Switzerland
  • Stadtspital Waid Zurich Zurich, Switzerland
View Trial Details
Completed

Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.

NCT02141516

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • 12, Novartis Investigational Site Florence, Italy
  • 11, Novartis Investigational Site Genova, Italy
  • 10, Novartis Investigational Site Milan, Italy
  • 14, Novartis Investigational Site Padova, Italy
View all 20 locations
View Trial Details
Completed

Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"

NCT00889967

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +8 more
Locations
  • Phoenix, Arizona, United States
  • Los Angeles, California, United States
  • Sacramento, California, United States
  • Torrance, California, United States
View all 37 locations
View Trial Details
Completed

Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation

NCT01890447

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +6 more
Locations
  • GSK Investigational Site San Severo (FG), Apulia, Italy
  • GSK Investigational Site Chiavari, Liguria, Italy
  • GSK Investigational Site Cuneo, Piedmont, Italy
  • GSK Investigational Site Ragusa (RG), Sicily, Italy
View Trial Details
Completed

Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients

NCT01375036

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • University of Arizona Tucson, Arizona, United States
  • Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
View all 31 locations
View Trial Details

Related conditions